I was hoping it wasn't a capital raising but kind of guessed it was due to the length of the halt (good news come quickly generally) - good way to knock the price further down
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%